New combo therapy aims to stop liver cancer from coming back after surgery
Disease control
Not yet recruiting
This study tests whether giving a mix of chemotherapy, immunotherapy, and targeted therapy before surgery can reduce the risk of liver cancer returning in patients with high-risk features. About 100 participants will either receive the combination treatment followed by surgery, o…
Phase: PHASE1, PHASE2 • Sponsor: BinYong Liang • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC